One in four oncologists fails to mention cost when discussing genomic testing
Nearly one in four oncologists discussing genomic testing with their patients rarely or never discusses the costs of testing, according to a new study led by American Cancer Society investigators. The study, appearing in ...
Nov 1, 2019
0
2